GTx Company Profile (NASDAQ:GTXI)

About GTx

GTx logoGTx, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other medical conditions. The Company is engaged in the development of selective androgen receptor modulators (SARMs). Its lead product candidate, enobosarm (GTx-024), had been evaluated in over 24 completed or ongoing clinical trials, including in approximately six Phase II and two Phase III clinical trials. The Company is also engaged in the development of GTx-758 (Capesaris), an oral nonsteroidal selective estrogen receptor alpha agonist, for secondary hormonal therapy in men with metastatic and high-risk non-metastatic castration resistant prostate cancer (CRPC). Its product candidate, Enobosarm, for the treatment of women with advanced androgen receptor (AR) positive triple-negative breast cancer (TNBC), is in Phase II clinical development-stage.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: GTXI
  • CUSIP: 40052B10
Key Metrics:
  • Previous Close: $4.88
  • 50 Day Moving Average: $5.36
  • 200 Day Moving Average: $2.71
  • 52-Week Range: $4.65 - $11.19
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.21
  • P/E Growth: 0.00
  • Market Cap: $77.68M
  • Outstanding Shares: 15,919,000
  • Beta: 1.68
Profitability:
  • Return on Equity: -177.62%
  • Return on Assets: -103.78%
Debt:
  • Current Ratio: 4.62%
  • Quick Ratio: 4.62%
Additional Links:
Companies Related to GTx:

Analyst Ratings

Consensus Ratings for GTx (NASDAQ:GTXI) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.00 (79.51% downside)

Analysts' Ratings History for GTx (NASDAQ:GTXI)
Show:
DateFirmActionRatingPrice TargetDetails
9/9/2016Jefferies Group LLCReiterated RatingHold$1.00View Rating Details
(Data available from 2/28/2015 forward)

Earnings

Earnings History for GTx (NASDAQ:GTXI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/1/2017($0.57)N/AView Earnings Details
11/3/2016Q3($0.05)($0.05)ViewN/AView Earnings Details
5/10/2016Q1($0.04)$0.01ViewN/AView Earnings Details
3/3/2016Q415($0.10)($0.04)ViewListenView Earnings Details
10/29/2015Q315($0.06)($0.04)ViewListenView Earnings Details
8/6/2015Q215($0.04)($0.34)ViewListenView Earnings Details
5/8/2015Q1($0.04)($0.04)ViewListenView Earnings Details
3/4/2015Q314($0.07)($0.05)ViewListenView Earnings Details
11/10/2014Q214($0.11)($0.06)ViewListenView Earnings Details
8/5/2014Q2($0.12)($0.15)ViewN/AView Earnings Details
5/8/2014Q114($0.12)($0.14)ViewN/AView Earnings Details
3/4/2014Q413($0.13)($0.12)ViewListenView Earnings Details
11/12/2013Q313($0.21)($0.14)ViewListenView Earnings Details
7/19/2013Q2 2013($0.22)($0.20)ViewN/AView Earnings Details
5/3/2013Q1 2013($0.21)($0.20)ViewListenView Earnings Details
2/21/2013Q4 2012($0.21)($0.17)ViewListenView Earnings Details
11/8/2012Q312($0.17)$0.12$1.93 millionViewN/AView Earnings Details
8/8/2012($0.17)($0.17)ViewN/AView Earnings Details
5/8/2012($0.17)($0.18)ViewN/AView Earnings Details
2/21/2012($0.17)($0.17)ViewN/AView Earnings Details
11/4/2011($0.18)($0.15)ViewN/AView Earnings Details
8/9/2011($0.19)($0.21)ViewN/AView Earnings Details
5/9/2011($0.13)($0.05)ViewN/AView Earnings Details
2/24/2011($0.16)($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for GTx (NASDAQ:GTXI)
Current Year EPS Consensus Estimate: $-1.34 EPS
Next Year EPS Consensus Estimate: $-1.16 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.04)($0.04)($0.04)
Q2 20161($0.05)($0.05)($0.05)
Q3 20161($0.05)($0.05)($0.05)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for GTx (NASDAQ:GTXI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for GTx (NASDAQ:GTXI)
Insider Ownership Percentage: 40.60%
Institutional Ownership Percentage: 96.51%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/14/2016Peak Foundation PyramidMajor ShareholderBuy7,716,049$0.81$6,249,999.69View SEC Filing  
6/16/2016Robert James WillsChairmanBuy100,000$0.65$65,000.00View SEC Filing  
3/1/2016J Kenneth GlassDirectorBuy44,000$0.60$26,400.00View SEC Filing  
1/26/2016Marc Steven HanoverCEOBuy4,000$0.65$2,600.00View SEC Filing  
1/25/2016Marc Steven HanoverCEOBuy12,813$0.63$8,072.19View SEC Filing  
1/19/2016Marc Steven HanoverCEOBuy25,000$0.50$12,500.00View SEC Filing  
1/14/2016Marc Steven HanoverCEOBuy25,000$0.49$12,250.00View SEC Filing  
12/24/2015J Kenneth GlassDirectorBuy100$0.79$79.00View SEC Filing  
12/22/2015J Kenneth GlassDirectorBuy1,907$0.78$1,487.46View SEC Filing  
12/21/2015J Kenneth GlassDirectorBuy39,900$0.78$31,122.00View SEC Filing  
5/19/2015J Kenneth GlassDirectorBuy24,500$1.25$30,625.00View SEC Filing  
5/14/2015Robert James WillsChairmanBuy46,140$0.96$44,294.40View SEC Filing  
5/8/2015Henry Patton DoggrellVPBuy25,477$0.80$20,381.60View SEC Filing  
5/8/2015Robert James WillsChairmanBuy50,000$0.80$40,000.00View SEC Filing  
4/22/2015J Kenneth GlassDirectorBuy10,000$0.72$7,200.00View SEC Filing  
4/21/2015J Kenneth GlassDirectorBuy11,608$0.71$8,241.68View SEC Filing  
4/15/2015J Kenneth GlassDirectorBuy3,300$0.72$2,376.00View SEC Filing  
4/10/2015J Kenneth GlassDirectorBuy16,400$0.67$10,988.00View SEC Filing  
9/23/2014Marc Steven HanoverCEOBuy5,000$0.75$3,750.00View SEC Filing  
9/17/2014Marc Steven HanoverCEOBuy10,000$0.74$7,400.00View SEC Filing  
8/21/2014Marc Steven HanoverCEOBuy20,000$1.00$20,000.00View SEC Filing  
8/19/2014Marc Steven HanoverCEOBuy10,000$1.01$10,100.00View SEC Filing  
8/8/2014Henry Patton DoggrellVPBuy10,000$0.97$9,700.00View SEC Filing  
8/8/2014Marc Steven HanoverCEOBuy30,000$0.93$27,900.00View SEC Filing  
8/7/2014Jason T ShackelfordInsiderBuy10,000$0.92$9,200.00View SEC Filing  
8/7/2014Marc Steven HanoverCEOBuy30,000$0.92$27,600.00View SEC Filing  
6/6/2014James T DaltonVPSell72,883$1.30$94,747.90View SEC Filing  
3/21/2014Jack Schulermajor shareholderSell1,192,251$1.84$2,193,741.84View SEC Filing  
8/22/2013Jack Schulermajor shareholderBuy93,777$1.36$127,536.72View SEC Filing  
8/21/2013Jack Schulermajor shareholderBuy309,591$1.42$439,619.22View SEC Filing  
7/9/2013Mark Edward MostellerCFOSell17,000$6.99$118,830.00View SEC Filing  
1/17/2013James T DaltonVPSell20,000$5.20$104,000.00View SEC Filing  
12/14/2012Timothy R G SearDirectorBuy50,000$4.33$216,500.00View SEC Filing  
8/27/2012J Kenneth GlassDirectorBuy10,000$3.76$37,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for GTx (NASDAQ:GTXI)
DateHeadline
News IconMyocardial Fibrosis - Pipeline Review, H2 2016 - New Market Study Published (NASDAQ:GTXI)
reports.pr-inside.com - February 2 at 11:11 PM
News IconGTx, Inc. (GTXI)’s Stock Formed A Several Months Bearish Multiple Bottom Pattern (NASDAQ:GTXI)
randolphguide.com - January 30 at 11:37 AM
News IconThe Cisco Systems Inc. (CSCO) Receives Overweight Rating from Piper Jaffray Cos (NASDAQ:GTXI)
avauncer.com - January 29 at 3:44 AM
biz.yahoo.com logoGTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:GTXI)
biz.yahoo.com - January 14 at 4:46 AM
News IconGTx Inc GTXI Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:GTXI)
www.bioportfolio.com - January 13 at 11:46 PM
publicnow.com logoWith the 7th Gen Intel® Core™ i7 Processor, NVIDIA® GeForce® GTX 10 Series ... (NASDAQ:GTXI)
www.publicnow.com - January 5 at 11:35 PM
biz.yahoo.com logoGTX INC /DE/ Files SEC form 8-K, Other Events (NASDAQ:GTXI)
us.rd.yahoo.com - December 21 at 11:30 PM
News IconIs GTx, Inc. (GTXI) A Good Stock To Buy? (NASDAQ:GTXI)
feedproxy.google.com - December 16 at 5:52 AM
4-traders.com logoGTX, INC. (NASDAQ:GTXI)
www.4-traders.com - December 12 at 5:41 PM
streetinsider.com logoJefferies Cuts Price Target on GTx, Inc. (GTXI) to $7 Following Enobosarm Trial Results (NASDAQ:GTXI)
www.streetinsider.com - December 9 at 10:14 AM
streetinsider.com logoGTx, Inc. (GTXI) Announces Early Initial Success from Ongoing Enobosarm Phase 2 in ER+/AR+ Breast Cancer (NASDAQ:GTXI)
www.streetinsider.com - December 8 at 11:14 PM
us.rd.yahoo.com logoGTx Reports Results from Ongoing Enobosarm Phase 2 Clinical Trial in ER+/AR+ Breast Cancer (NASDAQ:GTXI)
us.rd.yahoo.com - December 8 at 10:53 AM
investopedia.com logoGTx Announces 1-For-10 Reverse Stock Split (GTXI) (NASDAQ:GTXI)
www.investopedia.com - December 7 at 10:35 AM
biz.yahoo.com logoGTX INC /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statement (NASDAQ:GTXI)
biz.yahoo.com - December 6 at 10:40 AM
investopedia.com logoGTx Declares 1-For-10 Reverse Stock Split (GTXI) (NASDAQ:GTXI)
www.investopedia.com - December 6 at 10:40 AM
finance.yahoo.com logoGTx, Inc. Announces 1-for-10 Reverse Stock Split (NASDAQ:GTXI)
finance.yahoo.com - December 5 at 11:13 AM
capitalcube.com logoGTx, Inc. :GTXI-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016 (NASDAQ:GTXI)
www.capitalcube.com - December 1 at 10:41 AM
4-traders.com logoGTX INC /DE/ : Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:GTXI)
www.4-traders.com - November 30 at 9:14 AM
marketexclusive.com logoGTx,Inc. (NASDAQ:GTXI) Files An 8-K Other Events (NASDAQ:GTXI)
marketexclusive.com - November 30 at 9:14 AM
us.rd.yahoo.com logoEnobosarm Meets Pre-Specified Primary Efficacy Endpoint in Ongoing Phase 2 Clinical Trial in ER+/AR+ Breast Cancer (NASDAQ:GTXI)
us.rd.yahoo.com - November 29 at 4:55 PM
us.rd.yahoo.com logoEnobosarm Meets Pre-Specified Primary Efficacy Endpoint in Ongoing Phase 2 Clinical Trial in ER+/AR+ Breast Cancer (NASDAQ:GTXI)
us.rd.yahoo.com - November 29 at 4:55 PM
us.rd.yahoo.com logo7:04 am GTX announces that enobosarm achieved the pre-specified primary efficacy endpoint in both stage 1 and the ongoing stage 2 of its Phase 2 clinical trial in women with ER+,AR+ breast cancer (NASDAQ:GTXI)
us.rd.yahoo.com - November 29 at 4:55 PM
us.rd.yahoo.com logo7:04 am GTX announces that enobosarm achieved the pre-specified primary efficacy endpoint in both stage 1 and the ongoing stage 2 of its Phase 2 clinical trial in women with ER+,AR+ breast cancer (NASDAQ:GTXI)
us.rd.yahoo.com - November 29 at 4:55 PM
businesswire.com logoBusiness Wire Information (NASDAQ:GTXI)
www.businesswire.com - November 23 at 8:00 AM
finance.yahoo.com logoGTx Announces Webcast of Corporate Presentation at the 28th Annual Piper Jaffray Healthcare Conference (NASDAQ:GTXI)
finance.yahoo.com - November 23 at 8:00 AM
News IconGTx, Inc. GTXI Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:GTXI)
www.bioportfolio.com - November 20 at 5:06 PM
marketexclusive.com logoHere’s What We’re Watching When The Real Data Hits From GTx, Inc. (NASDAQ:GTXI) (NASDAQ:GTXI)
marketexclusive.com - November 18 at 4:51 PM
News IconHere’s What To Look For When The Real GTx, Inc. (GTXI) Data Hits (NASDAQ:GTXI)
feedproxy.google.com - November 17 at 3:27 PM
finance.yahoo.com logoBlog Coverage GTx Inc. Enobosarm Achieves Stage 1 Milestone (NASDAQ:GTXI)
finance.yahoo.com - November 17 at 8:30 AM
finance.yahoo.com logoGTx Achieves Second Stage 1 Milestone in Phase 2 Clinical Trial of Enobosarm in ER+/AR+ Breast Cancer (NASDAQ:GTXI)
finance.yahoo.com - November 16 at 8:43 AM
streetinsider.com logoGTx, Inc. (GTXI) Announces Enobosarm Phase 2 Achieved Stage 1 Milestone (NASDAQ:GTXI)
www.streetinsider.com - November 16 at 8:43 AM
finance.yahoo.com logoGTx Announces Webcast of Corporate Presentation at the Stifel 2016 Healthcare Conference (NASDAQ:GTXI)
finance.yahoo.com - November 11 at 8:53 AM
News IconGTx, Inc Clinical Trial Review, Market Growth, Medical Review and Forecast 2016 – 2020 (NASDAQ:GTXI)
www.medgadget.com - November 7 at 5:34 PM
biz.yahoo.com logoGTX INC /DE/ Files SEC form 10-Q, Quarterly Report (NASDAQ:GTXI)
biz.yahoo.com - November 7 at 5:34 PM
News IconGTx, Inc. Provides Corporate Update and Reports Third Quarter 2016 Financial Results (NASDAQ:GTXI)
www.biospace.com - November 3 at 10:54 PM
finance.yahoo.com logoGTx reports 3Q loss (NASDAQ:GTXI)
finance.yahoo.com - November 3 at 8:39 AM
tmcnet.com logoGTx Provides Corporate Update and Reports Third Quarter 2016 Financial Results (NASDAQ:GTXI)
www.tmcnet.com - November 3 at 8:39 AM
biz.yahoo.com logoGTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:GTXI)
biz.yahoo.com - November 3 at 8:39 AM
publicnow.com logoBIOSTAR Announces VR-Ready and Gaming Solution with its GTX 1060 Graphics Card with Dual-Fan Design - Designed for your First VR Gaming Rig (NASDAQ:GTXI)
www.publicnow.com - October 25 at 10:17 AM
publicnow.com logoDiscover GeForce PC Gaming: NVIDIA Introduces GeForce GTX 1050 and 1050 Ti (NASDAQ:GTXI)
www.publicnow.com - October 18 at 10:22 AM
publicnow.com logoGIGABYTE Introduces GeForce® GTX 1050 Ti and GTX 1050 Graphics Card Lines (NASDAQ:GTXI)
www.publicnow.com - October 18 at 10:22 AM
publicnow.com logoGIGABYTE Unveils GeForce® GTX 1080 XTREME GAMING WATERFORCE WB with ... (NASDAQ:GTXI)
www.publicnow.com - October 17 at 10:22 AM
biz.yahoo.com logoGTX INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial Cond (NASDAQ:GTXI)
biz.yahoo.com - October 12 at 10:22 AM
publicnow.com logoGTx Announces $14.0 Million Registered Direct Common Stock Offering (NASDAQ:GTXI)
www.publicnow.com - October 12 at 10:22 AM
publicnow.com logoGIGABYTE Releases GeForce® GTX 1080 Graphics Card Turbo OC Edition with ... (NASDAQ:GTXI)
www.publicnow.com - October 5 at 10:32 AM
einnews.com logoGlobal Capnography Market Technology, Applications, Key Players, Industry Insights, Outlook Report to 2027 (NASDAQ:GTXI)
www.einnews.com - September 30 at 10:29 AM
streetinsider.com logoGTx, Inc. (GTXI) Completes Stage 1 Milestone in Phase 2 Trial of Enobosarm in ER+/AR+ Breast Cancer (NASDAQ:GTXI)
www.streetinsider.com - September 8 at 5:15 PM
biz.yahoo.com logoGTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:GTXI)
biz.yahoo.com - September 8 at 5:15 PM
finance.yahoo.com logoGTx Achieves Stage 1 Milestone in Phase 2 Clinical Trial of Enobosarm in ER+/AR+ Breast Cancer (NASDAQ:GTXI)
finance.yahoo.com - September 8 at 9:12 AM
finance.yahoo.com logo7:02 am GTX achieves the Stage 1 milestone for the 9 mg cohort of its Phase 2 clinical trial of enobosarm to treat women with breast cancer; advances to stage 2 of trial (NASDAQ:GTXI)
finance.yahoo.com - September 8 at 9:12 AM

Social

What is GTx's stock symbol?

GTx trades on the NASDAQ under the ticker symbol "GTXI."

Where is GTx's stock going? Where will GTx's stock price be in 2017?

1 equities research analysts have issued twelve-month price objectives for GTx's shares. Their forecasts range from $1.00 to $1.00. On average, they anticipate GTx's stock price to reach $1.00 in the next twelve months.

When will GTx announce their earnings?

GTx is scheduled to release their next quarterly earnings announcement on Wednesday, March, 1st 2017.

Who owns GTx stock?

GTx's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Formanek Investment Trust (5.48%). Company insiders that own GTx stock include Henry Patton Doggrell, J Kenneth Glass, Marc Steven Hanover, Peak Foundation Pyramid and Robert James Wills.

How do I buy GTx stock?

Shares of GTx can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of GTx stock cost?

One share of GTx stock can currently be purchased for approximately $4.88.

GTx (NASDAQ:GTXI) Chart for Tuesday, February, 28, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for GTx (NASDAQ:GTXI)

Earnings History Chart

Earnings by Quarter for GTx (NASDAQ:GTXI)

Dividend History Chart

Dividend Payments by Quarter for GTx (NASDAQ:GTXI)

Last Updated on 2/28/2017 by MarketBeat.com Staff